WHO ICTRP trial
Effect of albumin with Standard Treatment in Liver Cirrhosis (Liver Disease)
CTRI/2020/11/028986 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2020/11/028986 |
|---|---|
| Public title | Effect of albumin with Standard Treatment in Liver Cirrhosis (Liver Disease) |
| Scientific title | Efficacy of Targeted And Response-Guided Albumin Therapy Versus Standard Medical Treatment In Outcomes Of Recurrent Ascites In Patients With Decompensated Cirrhosis- A Randomized Controlled Trial" |
| Primary sponsor | Institute of Liver and Biliary Sciences |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: K746- Other and unspecified cirrhosis ofliver |
| Interventions | Intervention1: Albumin with SMT: Patients with serum albumin 3 g/L with recurrent ascites - Will receive 20 % albumin at 60 grams/week until target serum albumin of 3.0 g/L is achieved following this patients would get 40 grams of albumin… |
| Registration date | Sep 11, 2020 |
| Target size | 100 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: